Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix)

Ching Hui Chen, Wen Ling Lee, I. Te Wang, Yuan Kuei Yen, Li Hsuan Chiu, Chii-Ruey Tzeng, Wei-Min Liu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: The safety and efficacy of the RevoLix 2-μ continuous wave laser for hysteroscopic myomectomy (HM) was evaluated. Materials and methods: A retrospective study was undertaken to evaluate 13 patients with symptomatic submucous myomas, who were treated with HM using a RevoLix laser application. The evaluation items included blood loss from surgery (estimated by the change between preoperative and postoperative hemoglobin levels), surgical time, amount of distension media, specimen volume retrieved, complications, and success rate. Results: The mean age of the patients was 38 years old; 10 patients were in the premenopausal status and nine patients were nullipara. The surgical time was 91 minutes, and the distension media requirement was 4500mL. The postoperative hemoglobin level decreased to 1.2g/dL compared with the preoperative status. Mean specimen volume retrieved was 13.7mm. No complications occurred. All patients reported significant improvement after HM during the 1-year follow-up. Conclusion: The use of the Revolix laser for HM seemed to be safe and effective in the management of symptomatic submucous myomas in this small population study.

Original languageEnglish
Pages (from-to)89-92
Number of pages4
JournalGynecology and Minimally Invasive Therapy
Volume2
Issue number3
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Uterine Myomectomy
Lasers
Myoma
Operative Time
Hemoglobins
Retrospective Studies
Safety
Population

Keywords

  • Electrosurgical operative hysteroscopy
  • Hysteroscopic myomectomy
  • RevoLix

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix). / Chen, Ching Hui; Lee, Wen Ling; Wang, I. Te; Yen, Yuan Kuei; Chiu, Li Hsuan; Tzeng, Chii-Ruey; Liu, Wei-Min.

In: Gynecology and Minimally Invasive Therapy, Vol. 2, No. 3, 08.2013, p. 89-92.

Research output: Contribution to journalArticle

@article{2c14fbaabf394307be6cbf257f0b17d9,
title = "Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix)",
abstract = "Objectives: The safety and efficacy of the RevoLix 2-μ continuous wave laser for hysteroscopic myomectomy (HM) was evaluated. Materials and methods: A retrospective study was undertaken to evaluate 13 patients with symptomatic submucous myomas, who were treated with HM using a RevoLix laser application. The evaluation items included blood loss from surgery (estimated by the change between preoperative and postoperative hemoglobin levels), surgical time, amount of distension media, specimen volume retrieved, complications, and success rate. Results: The mean age of the patients was 38 years old; 10 patients were in the premenopausal status and nine patients were nullipara. The surgical time was 91 minutes, and the distension media requirement was 4500mL. The postoperative hemoglobin level decreased to 1.2g/dL compared with the preoperative status. Mean specimen volume retrieved was 13.7mm. No complications occurred. All patients reported significant improvement after HM during the 1-year follow-up. Conclusion: The use of the Revolix laser for HM seemed to be safe and effective in the management of symptomatic submucous myomas in this small population study.",
keywords = "Electrosurgical operative hysteroscopy, Hysteroscopic myomectomy, RevoLix",
author = "Chen, {Ching Hui} and Lee, {Wen Ling} and Wang, {I. Te} and Yen, {Yuan Kuei} and Chiu, {Li Hsuan} and Chii-Ruey Tzeng and Wei-Min Liu",
year = "2013",
month = "8",
doi = "10.1016/j.gmit.2013.05.005",
language = "English",
volume = "2",
pages = "89--92",
journal = "Gynecology and Minimally Invasive Therapy",
issn = "2213-3070",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

TY - JOUR

T1 - Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix)

AU - Chen, Ching Hui

AU - Lee, Wen Ling

AU - Wang, I. Te

AU - Yen, Yuan Kuei

AU - Chiu, Li Hsuan

AU - Tzeng, Chii-Ruey

AU - Liu, Wei-Min

PY - 2013/8

Y1 - 2013/8

N2 - Objectives: The safety and efficacy of the RevoLix 2-μ continuous wave laser for hysteroscopic myomectomy (HM) was evaluated. Materials and methods: A retrospective study was undertaken to evaluate 13 patients with symptomatic submucous myomas, who were treated with HM using a RevoLix laser application. The evaluation items included blood loss from surgery (estimated by the change between preoperative and postoperative hemoglobin levels), surgical time, amount of distension media, specimen volume retrieved, complications, and success rate. Results: The mean age of the patients was 38 years old; 10 patients were in the premenopausal status and nine patients were nullipara. The surgical time was 91 minutes, and the distension media requirement was 4500mL. The postoperative hemoglobin level decreased to 1.2g/dL compared with the preoperative status. Mean specimen volume retrieved was 13.7mm. No complications occurred. All patients reported significant improvement after HM during the 1-year follow-up. Conclusion: The use of the Revolix laser for HM seemed to be safe and effective in the management of symptomatic submucous myomas in this small population study.

AB - Objectives: The safety and efficacy of the RevoLix 2-μ continuous wave laser for hysteroscopic myomectomy (HM) was evaluated. Materials and methods: A retrospective study was undertaken to evaluate 13 patients with symptomatic submucous myomas, who were treated with HM using a RevoLix laser application. The evaluation items included blood loss from surgery (estimated by the change between preoperative and postoperative hemoglobin levels), surgical time, amount of distension media, specimen volume retrieved, complications, and success rate. Results: The mean age of the patients was 38 years old; 10 patients were in the premenopausal status and nine patients were nullipara. The surgical time was 91 minutes, and the distension media requirement was 4500mL. The postoperative hemoglobin level decreased to 1.2g/dL compared with the preoperative status. Mean specimen volume retrieved was 13.7mm. No complications occurred. All patients reported significant improvement after HM during the 1-year follow-up. Conclusion: The use of the Revolix laser for HM seemed to be safe and effective in the management of symptomatic submucous myomas in this small population study.

KW - Electrosurgical operative hysteroscopy

KW - Hysteroscopic myomectomy

KW - RevoLix

UR - http://www.scopus.com/inward/record.url?scp=84901742827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901742827&partnerID=8YFLogxK

U2 - 10.1016/j.gmit.2013.05.005

DO - 10.1016/j.gmit.2013.05.005

M3 - Article

AN - SCOPUS:84901742827

VL - 2

SP - 89

EP - 92

JO - Gynecology and Minimally Invasive Therapy

JF - Gynecology and Minimally Invasive Therapy

SN - 2213-3070

IS - 3

ER -